Lista de obras -

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

artículo científico publicado en 2017

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

artículo científico publicado en 2017

31P-MR spectroscopy in monozygotic twins discordant for schizophrenia or schizoaffective disorder

artículo científico publicado en 2011

Aging effects on regional brain structural changes in schizophrenia

artículo científico publicado en 2011

Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder

artículo científico publicado en 2010

Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients

artículo científico publicado en 2012

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data

artículo científico publicado en 2021

Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia

artículo científico publicado en 2015

Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study

artículo científico publicado en 2010

Bioactive lipids in schizophrenia

artículo científico publicado en 2006

Brain structural correlates of schizotypy and psychosis proneness in a non-clinical healthy volunteer sample

artículo científico publicado en 2015

Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study

artículo científico publicado en 2014

Brain structure in schizophrenia vs. psychotic bipolar I disorder: A VBM study

artículo científico publicado en 2015

Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.

artículo científico publicado en 2007

Clinical trajectories in the ultra-high risk for psychosis population

artículo científico publicado en 2018

Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia

artículo científico publicado en 2015

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

artículo científico publicado en 2019

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

artículo científico publicado en 2020

Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophrenia

artículo científico publicado en 2010

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

artículo científico publicado en 2008

Default mode network activity in schizophrenia studied at resting state using probabilistic ICA.

artículo científico publicado en 2012

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

artículo científico publicado en 2016

Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groups

artículo científico publicado en 2002

Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100m.

artículo científico publicado en 2004

Effects of olanzapine on 31P MRS metabolic markers in schizophrenia

artículo científico publicado en 2012

Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.

artículo científico

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

artículo científico publicado en 2015

Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia

artículo científico publicado en 2007

F24. OMEGA-6 PUFA METABOLISM DISTURBED IN PHOSPHO- AND SPHINGOLIPIDS IN NEUROLEPTIC-NAïVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS – A FATTY ACID PROFILING STUDY IN FIVE LIPID FRACTIONS.

artículo científico publicado en 2018

F9. ALTERATIONS OF NEURONAL METABOLISM IN PATIENT SUBGROUPS AT ULTRA-HIGH RISK FOR PSYCHOSIS ACCORDING TO PACE CRITERIA – A 1H/31P-MR-SPECTROSCOPY STUDY.

artículo científico publicado en 2018

Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia

artículo científico publicado en 2003

Frequency domains of resting state default mode network activity in schizophrenia

GSK3B and schizophrenia: a case not closed

artículo científico publicado en 2009

Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia

artículo científico publicado en 2012

Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients

artículo científico publicado en 2015

Hippocampal metabolism and prefrontal brain structure: A combined 1H-MR spectroscopy, neuropsychological, and voxel-based morphometry (VBM) study

artículo científico publicado en 2017

Hippocampal structure, metabolism, and inflammatory response after a 6-week intense aerobic exercise in healthy young adults: a controlled trial

artículo científico publicado en 2015

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

artículo científico publicado en 2005

Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

artículo científico publicado en 2022

Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia

artículo científico publicado en 2006

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

artículo científico publicado en 2015

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2018

Neurometabolic patterns of an "at risk for mental disorders" syndrome involve abnormalities in the thalamus and anterior midcingulate cortex

scientific article published on 19 May 2020

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

artículo científico publicado en 2016

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

artículo científico publicado en 2020

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

artículo científico publicado en 2017

Organic bipolar disorder occurring together with spontaneous intracranial hypotension.

artículo científico publicado en 2004

PM485. Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis

artículo científico publicado en 2016

PM486. Disrupting GluR2-GAPDH Interaction Affects Axon and Dendrite Development.

artículo científico publicado en 2016

Phospholipase A2 activity is associated with structural brain changes in schizophrenia

artículo científico publicado en 2010

Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.

artículo científico publicado en 2010

Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence

artículo científico publicado en 2016

Polyunsaturated fatty acids in emerging psychosis

artículo científico

Polyunsaturated fatty acids in emerging psychosis: a safer alternative?

artículo científico

Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.

artículo científico publicado en 2003

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

scientific article published on 17 June 2020

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

artículo científico publicado en 2017

Prefrontal glutamatergic emotion regulation is disturbed in cluster B and C personality disorders - A combined 1H/31P-MR spectroscopic study.

artículo científico publicado en 2017

Prefrontal gyrification in psychotic bipolar I disorder vs. schizophrenia

artículo científico publicado en 2015

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

artículo científico publicado en 2019

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study

artículo científico publicado en 2016

Resting state functional connectivity of the hippocampus along the anterior-posterior axis and its association with glutamatergic metabolism.

artículo científico publicado en 2016

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

artículo científico publicado en 2018

Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia

artículo científico publicado en 2016

Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism

artículo científico publicado en 2012

State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.

artículo científico publicado en 2017

Superior temporal metabolic changes related to auditory hallucinations: a (31)P-MR spectroscopy study in antipsychotic-free schizophrenia patients

artículo científico publicado en 2013

T23. DYNAMICS OF NEURONAL METABOLISM AFTER THE ACUTE ONSET OF PSYCHOSIS – A TWO YEARS FOLLOW-UP 1H/31P-MR-SPECTROSCOPY STUDY IN NEUROLEPTIC NAïVE UHR TRANSITION PATIENTS.

artículo científico publicado en 2018

T25. ALTERATIONS OF PLASMA PHOSPHOLIPID FATTY ACID PROFILES ARE ASSOCIATED WITH LOCAL BRAIN STRUCTURAL ABNORMALITIES IN NEUROLEPTIC NAïVE FIRST-EPISODE PSYCHOSIS PATIENTS.

artículo científico publicado en 2018

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

artículo científico publicado en 2018

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

artículo científico publicado en 2018

Thalamocortical connectivity during resting state in schizophrenia

artículo científico publicado en 2013

The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia.

artículo científico publicado en 2004

The topical niacin sensitivity test: an inter- and intra-rater reliability study in healthy controls

artículo científico publicado en 2008

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Lista de obras de

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

31P-MR spectroscopy in monozygotic twins discordant for schizophrenia or schizoaffective disorder

Aging effects on regional brain structural changes in schizophrenia

Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder

Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data

Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia

Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study

Bioactive lipids in schizophrenia

Brain structural correlates of schizotypy and psychosis proneness in a non-clinical healthy volunteer sample

Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study

Brain structure in schizophrenia vs. psychotic bipolar I disorder: A VBM study

Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.

Clinical trajectories in the ultra-high risk for psychosis population

Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophrenia

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Default mode network activity in schizophrenia studied at resting state using probabilistic ICA.

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groups

Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100m.

Effects of olanzapine on 31P MRS metabolic markers in schizophrenia

Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia

F24. OMEGA-6 PUFA METABOLISM DISTURBED IN PHOSPHO- AND SPHINGOLIPIDS IN NEUROLEPTIC-NAïVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS – A FATTY ACID PROFILING STUDY IN FIVE LIPID FRACTIONS.

F9. ALTERATIONS OF NEURONAL METABOLISM IN PATIENT SUBGROUPS AT ULTRA-HIGH RISK FOR PSYCHOSIS ACCORDING TO PACE CRITERIA – A 1H/31P-MR-SPECTROSCOPY STUDY.

Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia

Frequency domains of resting state default mode network activity in schizophrenia

GSK3B and schizophrenia: a case not closed

Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia

Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients

Hippocampal metabolism and prefrontal brain structure: A combined 1H-MR spectroscopy, neuropsychological, and voxel-based morphometry (VBM) study

Hippocampal structure, metabolism, and inflammatory response after a 6-week intense aerobic exercise in healthy young adults: a controlled trial

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

Neurometabolic patterns of an "at risk for mental disorders" syndrome involve abnormalities in the thalamus and anterior midcingulate cortex

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

Organic bipolar disorder occurring together with spontaneous intracranial hypotension.

PM485. Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis

PM486. Disrupting GluR2-GAPDH Interaction Affects Axon and Dendrite Development.

Phospholipase A2 activity is associated with structural brain changes in schizophrenia

Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.

Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence

Polyunsaturated fatty acids in emerging psychosis

Polyunsaturated fatty acids in emerging psychosis: a safer alternative?

Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

Prefrontal glutamatergic emotion regulation is disturbed in cluster B and C personality disorders - A combined 1H/31P-MR spectroscopic study.

Prefrontal gyrification in psychotic bipolar I disorder vs. schizophrenia

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study

Resting state functional connectivity of the hippocampus along the anterior-posterior axis and its association with glutamatergic metabolism.

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia

Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism

State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.

Superior temporal metabolic changes related to auditory hallucinations: a (31)P-MR spectroscopy study in antipsychotic-free schizophrenia patients

T23. DYNAMICS OF NEURONAL METABOLISM AFTER THE ACUTE ONSET OF PSYCHOSIS – A TWO YEARS FOLLOW-UP 1H/31P-MR-SPECTROSCOPY STUDY IN NEUROLEPTIC NAïVE UHR TRANSITION PATIENTS.

T25. ALTERATIONS OF PLASMA PHOSPHOLIPID FATTY ACID PROFILES ARE ASSOCIATED WITH LOCAL BRAIN STRUCTURAL ABNORMALITIES IN NEUROLEPTIC NAïVE FIRST-EPISODE PSYCHOSIS PATIENTS.

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

Thalamocortical connectivity during resting state in schizophrenia

The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia.

The topical niacin sensitivity test: an inter- and intra-rater reliability study in healthy controls

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial